Literature DB >> 6994978

Influence of age and smoking on drug kinetics in man: studies using model compounds.

R E Vestal, A J Wood.   

Abstract

The effect of advanced age on drug disposition and response is the subject of an increasing number of research studies. Cigarette smoking and other environmental factors have been shown to influence the metabolism of some drugs. Studies of the effect of age on the pharmacokinetics of antipyrine, indocyanine green and propranolol indicate that the association of increased drug metabolism and smoking occurs predominantly in the young and that apparent liver blood flow declines with age regardless of smoking habits. This age related effect of smoking on drug metabolism may reflect a reduced capacity for hepatic enzyme induction in the elderly. The relative importance of age related alterations in the intrinsic drug metabolising ability of the liver and in liver blood flow depend on the pharmacokinetic characteristics of the drug being investigated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994978     DOI: 10.2165/00003088-198005040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  33 in total

1.  Induction of hepatic mixed function oxidases in senescent rodents.

Authors:  L S Birnbaum; M B Baird
Journal:  Exp Gerontol       Date:  1978       Impact factor: 4.032

2.  THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN.

Authors:  A D BENDER
Journal:  J Am Geriatr Soc       Date:  1965-03       Impact factor: 5.562

3.  Changes in cardiac output with age.

Authors:  M BRANDFONBRENER; M LANDOWNE; N W SHOCK
Journal:  Circulation       Date:  1955-10       Impact factor: 29.690

4.  Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat.

Authors:  R M Welch; C R Hughes; R L Deangelis
Journal:  Drug Metab Dispos       Date:  1976 Jul-Aug       Impact factor: 3.922

Review 5.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

6.  Effects of age and cigarette smoking on propranolol disposition.

Authors:  R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

7.  Effect of phenobarbital on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different age.

Authors:  R Kato; A Takanaka
Journal:  J Biochem       Date:  1968-03       Impact factor: 3.387

8.  Cadmium accumulation im man: influence of smoking, occupation, alcoholic habit and disease.

Authors:  G P Lewis; W J Jusko; L L Coughlin
Journal:  J Chronic Dis       Date:  1972-12

9.  Comparative metabolism of benzo[a]pyrene and drugs in human liver.

Authors:  J Kapitulnik; P J Popper; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1977-02       Impact factor: 6.875

10.  Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women.

Authors:  D W Nebert; J Winker; H V Gelboin
Journal:  Cancer Res       Date:  1969-10       Impact factor: 12.701

View more
  17 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

3.  Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.

Authors:  A M Taburet; A Devillers; P Thomare; J P Fillastre; P Veyssier; E Singlas
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

4.  Circadian changes in the pharmacokinetics of oral ketoprofen.

Authors:  M Ollagnier; H Decousus; Y Cherrah; F Levi; M Mechkouri; P Queneau; A Reinberg
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

5.  Factors affecting the pharmacokinetics of nifedipine.

Authors:  A G Renwick; J Le Vie; V F Challenor; D G Waller; B Gruchy; C F George
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.

Authors:  R G Watson; W Bastain; K A Larkin; J R Hayes; J A McAinsh; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 7.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

Review 9.  Issues in the perioperative management of the elderly patient with cardiovascular disease.

Authors:  John W Sear; Helen Higham
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  [On the pharmacokinetics of spironolactone in the elderly].

Authors:  U Abshagen; D Platt; H J Horn
Journal:  Klin Wochenschr       Date:  1981-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.